NCT00446069View on ClinicalTrials.gov

A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

August 31, 2008

Conditions

PainCancer

Interventions

DRUG

Morphine Sulphate

Egalet® morphine, Controlled Release 30 mg Oral tablet once daily for 2 weeks and MST Continus® 15 mg twice daily for 2 weeks

Trial Locations (8)

Unknown

Site 51, Kaunas

Site 50, Vilnius

Site 63, Bielsko-Biaia

Site 60, Bydgoszcz

Site 62, Poznan

Site 61, Warsaw

Site 64, Wroclaw

Site 65, Włocławek

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Egalet Ltd

INDUSTRY